Serdemetan (Compound)

Synonyms:Serdemetan, 881202-45-5, N1-(2-(1H-Indol-3-yl)ethyl)-N4-(pyridin-4-yl)benzene-1,4-diamine, JNJ-26854165, JNJ 26854165, Serdemetan [INN], JNJ-26854165 (Serdemetan), UNII-ID6YB4W3V8, ID6YB4W3V8, 1-N-[2-(1H-indol-3-yl)ethyl]-4-N-pyridin-4-ylbenzene-1,4-diamine

Pubchem:PUBCHEM:11609586

Id:c4c3c35e-9842-54d7-98fd-44d57542d6c2

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Serdemetan's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Serdemetan.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Serdemetan.

Results found

Linked to

	Label	Description
	BRD-K65924316-001-03-1 Substance (Entity type)	A Substance
	Serdemetan positively regulates CD9 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Serdemetan negatively regulates AURKA Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Serdemetan negatively regulates H1-2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Serdemetan positively regulates NPC1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Serdemetan negatively regulates SERPINA1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Serdemetan negatively regulates BAG3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	(Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxoindoline-5-sulfonamide in similarity relationship with Serdemetan Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Serdemetan positively regulates SQLE Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Serdemetan negatively regulates AUTS2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-K65924316-001-03-1

Substance (Entity type)

A Substance

Serdemetan positively regulates CD9

Knowledge Graph Assertion (Entity type)